Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-benzyloxycarbonyl-L-lysine>98.0%(HPLC)(T)25g

1-(AMINOMETHYL)CYCLOPENTANECARBONITRILE HCL, 95.0%, 1g

1-Benzyl-2-(4-(2-(2-phenyl-1H-benzo[d]imidazol-1-yl)-2-(piperidin-4-yl)ethoxy)phenyl)-1H-benzo[d]imidazole, 98%, 1g

6-Bromo-3-fluoro-2-methyl-pyridine, 98.0%, 10g

7-Bromo-2H-chromen-2-one, 95.0%, 5g

2-(5-Norbornene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium Tetrafluoroborate [Coupling Reagent for Peptide]>96.0%(N)25g

1-(2,4-Dichloropyridin-3-yl)ethanone, 95.0%, 250mg

(Z)-hex-3-en-1-yl (Z)-hex-3-enoate, 98%, 1g

2-Tolualdehyde, 98.0%, 100g

Acetic acid acetoxy-(4-chlorosulfonylphenyl)methyl ester, 97.0%, 100mg

AURAPTENE, 95%, 100mg

5-Methyl-2-pyridinesulfonamide, 95.0%, 5g

Benzyl 3-((tert-butoxycarbonyl)amino)-3-cyanopyrrolidine-1-carboxylate, 98%, 500mg